Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Antimicrobial resistance
Research has shown that veterinary nurses have a much higher level of infection from methicillin-resistant strains of bacteria than the general UK population.
We have reached crisis point

"It's a really scary situation at the moment!" was Matt Barnard's opening gambit as he spoke at the BVNA Congress on the subject of antimicrobial resistance (AMR).

He highlighted that AMR is present in every country in the world and he gave some dramatic examples – for example, carbapenem is no longer effective against Klebsiella pneumonia in hospitals and resistant strains of TB are increasing at an exponential rate worldwide.

Pharmaceutical companies do not have any real incentive to develop novel antibiotics because of the time that it takes to research, develop and licence them; the short time during which they are licensed exclusively before generic versions emerge; and the relatively small market globally for this class of medicine. Governments are particularly poor at providing realistic funding for antimicrobial products too, apparently preferring to fund high-profile, vote-catching projects.

"As nurses," Matt said, "we have to be aware of the dynamic exchange of resistant strains of bacteria that occurs in veterinary practice – from patient to patient, from the environment to the patient, and, importantly, between nurses and the patients." Research has shown that veterinary nurses have a much higher level of infection from methicillin-resistant strains of bacteria than the general UK population. It is now an occupational hazard.

Barrier nursing is, therefore, essential. It may be time consuming but it is critical and must be given top priority and the time that it needs. "Don't let the vets rush you," said Matt as he spent time with the audience going through all the items in practice that harbour infection and are agents for its spread.

In summary, Matt explained that veterinary nurses have a duty to:
• improve client awareness and understanding of the problems associated with AMR
• strengthen their knowledge (and that of their clients) and adopt an evidence-based approach to practice
• reduce the incidence of cross-infection in practice through effective sanitation and barrier nursing
• optimise the use of antibiotics.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.